The Globalists View Pandemics as a High Profit Investment Opportunity
“The last thing anyone is looking for is profit.” — Donald Trump, US President,
The coronavirus pandemic has exposed an intricate global web of corruption; a virus far more insidious than Covid-19. The virus of corruption has infected virtually every institution that governs or influences public health policies around the globe. Governments, national and international institutions—including foundations, and universities that profit handsomely from their “nonprofit” – tax exempt status, and the media – are infected; as is the media, both corporate- owned and government-supported media.
The allure of a coronavirus vaccine is the vast global market for this vaccine; a market that encompasses seven billion people. The allure of a Covid-19 vaccine is that the demand for the vaccine will undoubtedly translate into trillions of dollars. Not only will the manufacturers profit, but investors and a global network of public-private partnerships will profit as well.
A powerful international network of “public-private partnerships” between government agencies, global financial institutions, pharmaceutical companies, academic institutions, “non-profits” and “philanthropic” foundations have been actively laid strategic plans before the Covid-19 pandemic, having recognized that a pandemic presents enormous opportunities
The leading institution is the World Bank which has developed “some of the most innovative catastrophe risk insurance instruments in the market” ostensibly, to help developing countries manage risk. In the past ten years the institution has executed approximately $1.6 billion in catastrophe risk transactions
In 2016, at the G7 meeting in Japan, the World Bank created the Pandemic Emergency Financing Facility (PEF). In January 2017, the Center for Global Health Science and Security (GHSS)[ii] at Georgetown University Medical Center in partnership with the Harvard Global Health Institute ,[iii] organized a gathering of global health experts from academia, government and advocacy. Speakers emphasized that a critical step the Trump administration needs to take, to prepare for a pandemic, is to set up a funding mechanism to pay for pandemic response.
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984, emphasized his experience in dealing with five presidents:
“If there’s one message that I want to leave with you today based on my experience, it is that there is no question that there will be a challenge to the coming administration in the arena of infectious diseases. “There will be a surprise outbreak during the [Trump] administration’s first term…We need a public health emergency fund…”
Ashish K. Jha, MD, MPH, director of the Harvard Global Health Institute agreed stating: “If you think about all the things that could very quickly devastate a population, devastate a country, pandemics is really near if not at the top of that list.”
Other speakers agreed: “a pandemic is inevitable… the incoming Trump administration [should] take steps towards improving pandemic preparedness… something will happen at an unexpected point… The threat of a pandemic is very real….there are also a lot of very exciting avenues to improve our approaches and to explore new initiatives.”
In June 2017, the World Bank launched pandemic bonds with $500 million to provide financial support to PEF which would distribute money to countries facing a major disease outbreak with pandemic potential. PEF has two financing windows: an insurance window with premiums consisting of bonds and swaps, funded by Japan and Germany; and a “cash” window.
This financing structure combines funding from the bonds issued with over-the-counter derivatives that transfer pandemic outbreak risk to derivative counterparties. The structure was designed to attract a wider, more diverse set of investors. The transaction was oversubscribed by 200% reflecting overwhelming “investor confidence”; that confidence lowered the total amount transferred to the market in bonds and derivatives to $425 million.
Clearly, there is a financial incentive to investing in pandemic risk. The global public-private partnerships wasted no time in preparing for the investment opportunities that the Covid-19 pandemic presents.